Mammoth Biosciences, GSK partner on CRISPR-based Covid-19 diagnostic

Published on:

The companies plan to apply with the Food and Drug Administration for an emergency use authorization by the end of the year. Mammoth’s technology is based on the research of CRISPR pioneer Jennifer Doudna.

Read more    Source:

Leave a Reply